Basilea Pharmaceutica AG (BPMUF)
65.10
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Basilea Pharmaceutica Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Kuros Biosciences Ltd. | 966.82M |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 29.25B |
| AC Immune SA | 206.40M |
| CRISPR Therapeutics AG | 3.028B |
Enterprise Value Related Metrics
| Earnings Yield | 5.64% |
| Operating Earnings Yield | 6.98% |
| Normalized Earnings Yield | 5.641 |